Sartorius AG SRT.DE

Sartorius AG is a medical instruments and supplies company. Founded in 1870, the company operates through two segments: Lab Products & Services and Bioprocess Solutions. The company serves customers in a wide range of industries, including quality control and testing, life science research, biopharmaceutical manufacturing, cannabis testing, paint mixing, food and beverage and environmental. Operating internationally, the company has headquarters in Goettingen, Germany.

The company offers a broad selection of products, including a live cell analysis system, cell analysis reagents, cell culture media, bioreactors and software applications for bioreactors. Lab filtration and purification devices are also available, as well as liquid storage and shipping management products. Services such as bioprocess development engineering, instrument, validation and a protein express system are also available through the company.

Sartorius AG stock is available on the Xetra stock exchange under the ticker SRT.DE Stock for the company has been listed on the exchange since May 1999. On December 9, 2020, the company announced that it had acquired WaterSep BioSeparations, a filtrations expert. In June 2021, Sartorius acquired Xell AG, a cell culture specialist. On 8 February 2022, the company completed its acquisition of Novasep’s chromatography division.

Be among the first to learn about the latest SRT.DE stock news by adding it to your eToro watchlist.